These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 31678050)

  • 1. The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?
    Wieczorska K; Stolarek M; Stec R
    Clin Colorectal Cancer; 2020 Mar; 19(1):5-12. PubMed ID: 31678050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gut microbiota-immunity axis in patients undergoing surgery for colorectal cancer: Focus on short and long-term outcomes.
    Bartolini I; Risaliti M; Ringressi MN; Melli F; Nannini G; Amedei A; Muiesan P; Taddei A
    World J Gastroenterol; 2020 May; 26(20):2498-2513. PubMed ID: 32523307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Fong W; Li Q; Yu J
    Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutraceuticals in colorectal cancer: A mechanistic approach.
    Rossi M; Mirbagheri SEYEDS; Keshavarzian A; Bishehsari F
    Eur J Pharmacol; 2018 Aug; 833():396-402. PubMed ID: 29935172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of gut microbiota in carcinogenesis and treatment for colorectal cancer].
    Zhang W; Jiang KW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):516-520. PubMed ID: 32842435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Gut Microbiome Contributes to Intestinal Oxidative Stress, Barrier Dysfunction, Inflammation and Systemic Autoimmune Responses in MRL/lpr Mice.
    Wang H; Wang G; Banerjee N; Liang Y; Du X; Boor PJ; Hoffman KL; Khan MF
    Front Immunol; 2021; 12():651191. PubMed ID: 33912174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive values of colon microbiota in the treatment response to colorectal cancer.
    Galan-Ros J; Ramos-Arenas V; Conesa-Zamora P
    Pharmacogenomics; 2020 Sep; 21(14):1045-1059. PubMed ID: 32896201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome as a treatment in colorectal cancer.
    Khan M; Shah S; Shah W; Khan I; Ali H; Ali I; Ullah R; Wang X; Mehmood A; Wang Y
    Int Rev Immunol; 2024; 43(4):229-247. PubMed ID: 38343353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the gut microbiota in tumor, immunity, and immunotherapy.
    Xie Y; Liu F
    Front Immunol; 2024; 15():1410928. PubMed ID: 38903520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
    Bruneau A; Baylatry MT; Joly AC; Sokol H
    Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusobacterium and Enterobacteriaceae: important players for CRC?
    Allen-Vercoe E; Jobin C
    Immunol Lett; 2014 Dec; 162(2 Pt A):54-61. PubMed ID: 24972311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
    Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
    Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers.
    Kikuchi T; Mimura K; Ashizawa M; Okayama H; Endo E; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Shimada K; Yoshimura K; Tsunoda T; Kono K
    Cancer Immunol Immunother; 2020 Jan; 69(1):23-32. PubMed ID: 31768581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy.
    Ramírez-Labrada AG; Isla D; Artal A; Arias M; Rezusta A; Pardo J; Gálvez EM
    Trends Cancer; 2020 Feb; 6(2):86-97. PubMed ID: 32061309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
    Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
    Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
    World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like Receptor-6 Signaling Prevents Inflammation and Impacts Composition of the Microbiota During Inflammation-Induced Colorectal Cancer.
    Kim JH; Kordahi MC; Chac D; DePaolo RW
    Cancer Prev Res (Phila); 2020 Jan; 13(1):25-40. PubMed ID: 31771941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.